Industry reports
Editor highlights

Publication dates

data types

Erythropoietin Market and Forecasts, April 2014

You might be interested in: biosimilar, tobacco production, protein, more »


 
1-10 of 61 reports for Erythropoietin

Biosimilar Sector in Europe

  • Industry report
  • September 2013
  • 16 pages

... Trial data or post marketing surveillance data that switching to and from different biopharmaceuticals leads to safety concerns. Keywords: biopharmaceuticals, biosimilars, erythropoietin, filgrastim ...

Biosimilar Market in Europe

  • Industry report
  • September 2013
  • 16 pages

... Trial data or post marketing surveillance data that switching to and from different biopharmaceuticals leads to safety concerns. Keywords: biopharmaceuticals, biosimilars, erythropoietin, filgrastim ...

Blood Cell Market Brief

  • Industry report
  • August 2012
  • 3 pages
  • by Governmental Agency

... And morbidities independent of the primary disease. For patients with low erythropoietin levels relative to the degree of anaemia, erythropoietin may increase haemoglobin sufficiently; otherwise, red blood cell ...

Biosimilar Business in Iran and South Korea

  • Industry report
  • May 2012
  • 8 pages

... As an example according to a published report, among several recombinant erythropoietins manufactured in asia none was comparable with the originator product from structural point of view [11]. However ...

Pharmaceutical Market Overview

  • Industry report
  • September 2013
  • 42 pages

... Muscle increase in strength and volume kidney stimulation of erythropoietin production bone marrow stimulation of stem cells bone accelerated linear growth, closure of epiphyses the role ...

Clinical Trial in Canada and The United States : Innovation and Technology Trends

  • Industry report
  • April 2012
  • 27 pages

... In countries with emerging economies attractive preclinical studies Cyclosporine mazzeo 2009 erythropoietine yatsiv 2005, zhang 2009 Progesterone xiao 2008 Statins tapia-perez 2008 Vit d and ...

The Indian Biosimilar Industry

  • Industry report
  • February 2012
  • 6 pages

... And safety studies (in the clinical section). In the case of biosimilars containing recombinant human erythropoietins, the ema guideline has been recently revised9, drawing on experience gained from ...

Biotechnology Industry in The United States and Japan

  • Industry report
  • December 2013
  • 8 pages

... For science teaching excellence. Key milestones 1980 amgen is established in thousand oaks, california 1983 amgen employee fu-kuen lin clones erythropoietin gene 1985 research team at amgen clones ...

Cancer Drug Business in The United States and Japan

  • Industry report
  • January 2013
  • 6 pages

... Research report added erythropoietin market to its database. Alina martin pre book price figure 1tmr usa - canada toll free 866-552-3453 $4315 ...

Biopharmaceutical in India and The United States : Industry Overview and Key Players

  • Industry report
  • June 2012
  • 19 pages

... With a breakdown of immune tolerance to erythropoietin treatment resulting in neutralizing antibody formation not only against the recombinant protein, but also the native erythropoietin (47). The sharp increase ...

» Purchase Premium Reports (From $ 250 - $ 10 000)

20 reports for Erythropoietin
Erythropoietin: Pipeline™ Developer: Patent Report

Erythropoietin: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.